MVZ Hamatologie-Onkologie Mayen/Koblenz GmbH

Mayen 4 trials 2 recruiting

4 Registered trials

2 Currently recruiting

Organisation

MVZ Hamatologie-Onkologie Mayen/Koblenz GmbH

Location

Mayen, Germany

Identifier

ORG-100043419

Address

Kelberger Straße 39, 56727, Germany

Departments

Hämatologie und Onkologie
Hämatologie/Onkologie
MVZ
Oncology

Clinical trials at this site (4)

Search interface

A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX (GAVE) COMPARED TO OBINUTUZU… Recruiting

2023-506414-46-00 High risk patients defined as having at least one of th 5 2022-04-22
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23